Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive analyses of cuproptosis-related gene CDKN2A on prognosis and immunologic therapy in human tumors

7 Apr 2023

Abstract excerpt

Recent studies have identified a novel programmed cell death based on copper, named cuproptosis. However, as an anti-cuproptosis gene, the functional roles, definite mechanisms and prognostic value of CDKN2A in pan-cancer are largely unclear. The GEPIA2, cancer genome atlas (TCGA), the tumor immune estimation resource 2.0 and CPTAC databases were performed to validate the differential expression of CDKN2A in 33...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37026918
DOI: 10.1097/md.0000000000033468

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive analyses of cuproptosis-related gene CDKN2A on prognosis and immunologic therapy in human tumorsPMID 37026918Read ↗

Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysisSemantic proximity Read ↗

Comprehensive analysis of cuproptosis‐related gene expression and positive correlations with CD4+ T cell infiltration in head and neck squamous cell carcinomaSemantic proximity Read ↗

Cuproptosis-associated CDKN2A is targeted by plicamycin to regulate the microenvironment in patients with head and neck squamous cell carcinomaSemantic proximity Read ↗

Systematic analysis identifies CDKN2A as a prognostic biomarker for hepatocellular carcinomaSemantic proximity Read ↗

Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinomaSemantic proximity Read ↗

Pan‐cancer analyses reveal molecular and clinical characteristics of cuproptosis regulatorsSemantic proximity Read ↗

Molecular Subtyping Based on Cuproptosis-Related Genes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell CarcinomaSemantic proximity Read ↗

Pan-cancer patterns of cuproptosis markers reveal biologically and clinically relevant cancer subtypesSemantic proximity Read ↗

A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivitySemantic proximity Read ↗

Comprehensive analysis of prognosis and tumor immune microenvironment of cuproptosis-related gene CDKN2A in lung adenocarcinomaSemantic proximity Read ↗

Comprehensive Analysis of Cuproptosis-related Genes Involved in Prognosis and Tumor Microenvironment Infiltration of Colorectal CancerSemantic proximity Read ↗

A Pan-Cancer Analysis of prognosis and immunity of cuproptosis-related gene FDX1Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.